Delivery Order SPE2DB22D1103-SPE2DB25FTNF5
Award Date
5/23/25
Potential Completion Date
5/27/25
Potential Value
$2.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DUPIXENT 300 MG/2 ML SYRINGE 2ML, a specialty pharmaceutical product, with a ceiling value of $4,131.19 and a period of performance through March 12, 2025. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DUPIXENT 300 MG/2 ML SYRINGE 2ML, a pharmaceutical product, with a ceiling value of $35,936.99. The contract is a firm-fixed price delivery order with a period of performance extending through May 22, 2025. The contract does not have a set-aside designation, indicating open...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of DUPIXENT 300 MG/2 ML SYRINGE 2ML, a pharmaceutical product, with an ultimate completion date of July 3, 2024 and a ceiling value of $12,498.56. The contract is a Firm Fixed Price delivery order, without any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DUPIXENT 300 MG/2 ML SYRINGE 2ML, with a ceiling value of $3,418.92 and a period of performance through May 22, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,261.12 firm fixed-price contract is for the supply of DUPIXENT 300 MG/2 ML SYRINGE 2ML, with a period of performance through January 15, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of DUPIXENT 300 MG/2 ML SYRINGE 2ML. The contract has a firm fixed price of $5,220.72 and a completion date of May 13, 2025. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DUPIXENT 300 MG/2 ML SYRINGE 2ML, a pharmaceutical product, with a ceiling value of $12,326.18 and a period of performance through March 12, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation. Amerisourcebergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DUPIXENT 300 MG/2 ML SYRINGE 2ML, a specialty pharmaceutical product. The award has a ceiling value of $7,663.16 and a completion date of May 29, 2024. The contract is a Firm Fixed Price arrangement, with no set-aside designation. AmerisourceBergen holds a larger Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of DUPIXENT 300 MG/2 ML SYRINGE 2ML. The contract has a ceiling value of $15,449.71 and a period of performance through February 21, 2024. The contract is a firm fixed price delivery order, with no set-aside designation indicated. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a federal delivery order contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of DUPIXENT 300 MG/2 ML SYRINGE 2ML, a specialty pharmaceutical product. The award has a ceiling value of $14,080.32 and an ultimate completion date of February 11, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...